Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The promise of microRNA-based therapies in Alzheimer’s disease: challenges and perspectives
Hannah Walgrave, Lujia Zhou, Bart De Strooper, et al.
Molecular Neurodegeneration (2021) Vol. 16, Iss. 1
Open Access | Times Cited: 86

Showing 26-50 of 86 citing articles:

Unlocking the Therapeutic Promise of miRNAs in Promoting Amyloid-β Clearance for Alzheimer's Disease.
Vajinder Kaur, Aditya Sunkaria
Behavioural Brain Research (2025), pp. 115505-115505
Closed Access
Dysregulated miRNAs in Progression and Pathogenesis of Alzheimer’s Disease
Tania Arora, Vikash Prashar, Randeep Singh, et al.
Molecular Neurobiology (2022) Vol. 59, Iss. 10, pp. 6107-6124
Closed Access | Times Cited: 24
β-Amyloid targeting nanodrug for neuron-specific delivery of nucleic acids in Alzheimer's disease mouse models
Liron L. Israel, Tao Sun, Oliver Braubach, et al.
Journal of Controlled Release (2023) Vol. 361, pp. 636-658
Open Access | Times Cited: 13
Micro-RNA profiles of pathology and resilience in posterior cingulate cortex of cognitively intact elders
Christy M. Kelley, Bryan Maloney, John S. Beck, et al.
Brain Communications (2024) Vol. 6, Iss. 2
Open Access | Times Cited: 4
The complex effects of miR-146a in the pathogenesis of Alzheimer’s disease
Yunfan Long, Jiajia Liu, Yu Wang, et al.
Neural Regeneration Research (2024) Vol. 20, Iss. 5, pp. 1309-1323
Open Access | Times Cited: 4
Role of the Cholinergic Anti-Inflammatory Reflex in Central Nervous System Diseases
Iván Ramos-Martínez, Maria Carmen Rodríguez, Marco Cerbón, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 24, pp. 13427-13427
Open Access | Times Cited: 27
Intranasal delivery: An attractive route for the administration of nucleic acid based therapeutics for CNS disorders
Pranav Shah, Manisha Lalan, Kalyani Barve
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 19
Neurotoxic Astrocytes Directly Converted from Sporadic and Familial ALS Patient Fibroblasts Reveal Signature Diversities and miR-146a Theragnostic Potential in Specific Subtypes
Cátia Gomes, Catarina Sequeira, Shibi Likhite, et al.
Cells (2022) Vol. 11, Iss. 7, pp. 1186-1186
Open Access | Times Cited: 18
Emerging Role of miR-21-5p in Neuron–Glia Dysregulation and Exosome Transfer Using Multiple Models of Alzheimer’s Disease
Gonçalo Garcia, Sara Pinto, Sofia Ferreira, et al.
Cells (2022) Vol. 11, Iss. 21, pp. 3377-3377
Open Access | Times Cited: 18
State‐of‐the‐art therapy for Down syndrome
Nicola Lorenzón, Juanluis Musoles‐Lleó, Federica Turrisi, et al.
Developmental Medicine & Child Neurology (2023) Vol. 65, Iss. 7, pp. 870-884
Closed Access | Times Cited: 11
The Role of microRNAs in Epigenetic Regulation of Signaling Pathways in Neurological Pathologies
П. П. Трегуб, Irada Ibrahimli, Anton S. Averchuk, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 16, pp. 12899-12899
Open Access | Times Cited: 10
Unveiling the Role of Novel miRNA PC-5P-12969 in Alleviating Alzheimer’s Disease
Murali Vijayan, P. Hemachandra Reddy
Journal of Alzheimer s Disease (2024) Vol. 98, Iss. 4, pp. 1329-1348
Closed Access | Times Cited: 3
miRNAs and Alzheimer’s Disease: Exploring the Role of Inflammation and Vitamin E in an Old-Age Population
Virginia Boccardi, Giulia Poli, Roberta Cecchetti, et al.
Nutrients (2023) Vol. 15, Iss. 3, pp. 634-634
Open Access | Times Cited: 9
Stress, microRNAs, and stress-related psychiatric disorders: an overview
Laura Musazzi, Jessica Mingardi, Alessandro Ieraci, et al.
Molecular Psychiatry (2023) Vol. 28, Iss. 12, pp. 4977-4994
Closed Access | Times Cited: 9
Cholinergic blockade of neuroinflammation: from tissue to RNA regulators
Tamara Zorbaz, Nimrod Madrer, Hermona Soreq
Neuronal Signaling (2022) Vol. 6, Iss. 1
Open Access | Times Cited: 15
MiR-431 attenuates synaptic plasticity and memory deficits in APPswe/PS1dE9 mice
Jianwei Ge, Zhiwei Xue, Shu Shu, et al.
JCI Insight (2023) Vol. 8, Iss. 12
Open Access | Times Cited: 8
Insights into role of microRNA in Alzheimer's disease: From contemporary research to bedside perspective
Mounisha Bandakinda, Awanish Mishra
International Journal of Biological Macromolecules (2023) Vol. 253, pp. 126561-126561
Closed Access | Times Cited: 8
Obesity-induced chronic low-grade inflammation in adipose tissue: A pathway to Alzheimer’s disease
Zhai Weijie, Zhao Meng, Wei Chunxiao, et al.
Ageing Research Reviews (2024) Vol. 99, pp. 102402-102402
Open Access | Times Cited: 2
Spatiotemporal Dysregulation of Neuron–Glia Related Genes and Pro-/Anti-Inflammatory miRNAs in the 5xFAD Mouse Model of Alzheimer’s Disease
M. Di Ianni, Miriam Corraliza-Gómez, Tiago Costa-Coelho, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 17, pp. 9475-9475
Open Access | Times Cited: 2
NACC2, a molecular effector of miR-132 regulation at the interface between adult neurogenesis and Alzheimer’s disease
Amber Penning, Sarah Snoeck, Oxana Garritsen, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 2
Adult Neural Stem Cell Regulation by Small Non-coding RNAs: Physiological Significance and Pathological Implications
Amber Penning, Giorgia Tosoni, Oihane Abiega, et al.
Frontiers in Cellular Neuroscience (2022) Vol. 15
Open Access | Times Cited: 12
Implications of miRNAs dysregulation in amyotrophic lateral sclerosis: Challenging for clinical applications
Yuka Koike, Osamu Onodera
Frontiers in Neuroscience (2023) Vol. 17
Open Access | Times Cited: 7
News & views: anti-amyloid antibodies and novel emerging approaches to Alzheimer’s disease in 2023
Sam Gandy
Molecular Neurodegeneration (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 7
Antisense therapy: a potential breakthrough in the treatment of neurodegenerative diseases
Roberta Romanò, Cecilia Bucci
Neural Regeneration Research (2023) Vol. 19, Iss. 5, pp. 1027-1035
Open Access | Times Cited: 6
Targeting non-coding RNAs: Perspectives and challenges of in-silico approaches
Roberta Rocca, Katia Grillone, Emanuele Liborio Citriniti, et al.
European Journal of Medicinal Chemistry (2023) Vol. 261, pp. 115850-115850
Open Access | Times Cited: 6

Scroll to top